Trademark Overview
On Friday, March 13, 2026, a trademark application was filed for MLI2 with the United States Patent and Trademark Office. The USPTO has given the MLI2 trademark a serial number of 99702206. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, March 13, 2026. The MLI2 trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Software as a service (SAAS) services featuring software for pharmacovigilance, adverse event data analysis, medication safety monitoring, and analysis of FDA Adverse Event Reporting System (FAERS) data.